A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin

Abstract

These data show that delafloxacin is effective in the treatment of ABSSSIs and is well tolerated.